Sacroiliitis and severe disability due to isotretinoin therapy

Rheumatology International

Volumn 30, Issue 7, 2010, Pages 985-986

  Rozin, Alexander P ^b   Kagna, Olga ^a   Shiller, Yizhak ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b NONE

Author keywords

Acne; Disability; Isotretinoin; Sacroiliitis; Synacten depo

Indexed keywords

ETODOLAC; ETOPAN; ISOTRETINOIN; TETRACOSACTIDE; UNCLASSIFIED DRUG;

ACNE; ADULT; ARTICLE; BONE SCINTISCANNING; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; DISABILITY; DISEASE SEVERITY; ELECTROMYOGRAPHY; FOLLOW UP; HUMAN; MALE; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROBABILITY; RATING SCALE; SACROILIITIS; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACNE VULGARIS; ADRENOCORTICOTROPIC HORMONE; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRALGIA; ARTHRITIS; DERMATOLOGIC AGENTS; DISABILITY EVALUATION; EDEMA; ETODOLAC; HUMANS; IATROGENIC DISEASE; ISOTRETINOIN; LOW BACK PAIN; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE WEAKNESS; SACROILIAC JOINT; TREATMENT OUTCOME; WHOLE BODY IMAGING;

EID: 77955093163     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1014-4     Document Type: Article

References (10)

1. Elias LM, Gomez MI, Torelo A, Boixeda JP, Ledo A (1991) Acne fulminans and bilateral seronegative sacroiliitis triggered by isotretinoin. J Dermatol 18:366-367.
2. Bachmeyer C, Charoud A, Turc Y, Callot V, Blum L, Aractingi S (2003) Isotretinoin induced bilateral sacroiliitis. Dermatology 206:285-286. doi:10.1159/000069849. (Pubitemid 36407844)
3. Eksioglu E, Oztekin F, Unlu E, Cacki A, Keylik B, Karaduvut IK (2007) Sacroiliitis and polyneuropathy during isotretinoin treatment. Clin Exp Dermatol 33:122-124. doi:10.1111/j.1365-2230.2007.02532.x.
4. Pritchard J, Appleton R, Howard R, Hughes RA (2004) Guillain-Barre syndrome seen in users of isotretinoin. BMJ 328:1537.
5. Naranjo CA, Busto U, Sellers EM, Borraz Y, Hidalgo R, Andrade RJ (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245. (Pubitemid 12149145)
6. BoVa MJ, Dave VK (1994) Facial cellulitis during oral isotretinoin treatment for acne. J Am Acad Dermatol 31:800-802. doi:10.1016/S0190-9622(09) 80046-7.
7. Landau M, Mesterman R, Ophir J, Mevorah B, Alcalay J, Harel A et al (2001) Clinical significance of markedly elevated serum kinase levels in patients with acne on isotretinoin. Acta Derm Venereol 81:350-352. doi:10.1080/000155501317140070. (Pubitemid 34015491)
8. Trauner MA, Ruben BS (1999) Isotretinoin induced rhabdomyolysis? A case report. Dermatol Online J 5:2.
9. Scheinfeld N, Bangalore S (2006) Facial edema induced by isotretinoin use: a case and a review of the side eVects of isotretinoin. J Drugs Dermatol 5:467-468.
10. Madan V, Muston HL, Marsland AM (2007) Isotretinoin-induced pleuritic chest pain. Br J Dermatol 156:385-386. doi:10.1111/j.1365-2133.2006.07618.x. (Pubitemid 46095976)